BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 16651415)

  • 1. Dysregulated human myeloid nuclear differentiation antigen expression in myelodysplastic syndromes: evidence for a role in apoptosis.
    Briggs RC; Shults KE; Flye LA; McClintock-Treep SA; Jagasia MH; Goodman SA; Boulos FI; Jacobberger JW; Stelzer GT; Head DR
    Cancer Res; 2006 May; 66(9):4645-51. PubMed ID: 16651415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retroviral mediated expression of the human myeloid nuclear antigen in a null cell line upregulates Dlk1 expression.
    Doggett KL; Briggs JA; Linton MF; Fazio S; Head DR; Xie J; Hashimoto Y; Laborda J; Briggs RC
    J Cell Biochem; 2002; 86(1):56-66. PubMed ID: 12112016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation and specificity of MNDA expression in monocytes, macrophages, and leukemia/B lymphoma cell lines.
    Briggs RC; Kao WY; Dworkin LL; Briggs JA; Dessypris EN; Clark J
    J Cell Biochem; 1994 Dec; 56(4):559-67. PubMed ID: 7890814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon alpha selectively affects expression of the human myeloid cell nuclear differentiation antigen in late stage cells in the monocytic but not the granulocytic lineage.
    Briggs R; Dworkin L; Briggs J; Dessypris E; Stein J; Stein G; Lian J
    J Cell Biochem; 1994 Feb; 54(2):198-206. PubMed ID: 8175894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MNDA binds NPM/B23 and the NPM-MLF1 chimera generated by the t(3;5) associated with myelodysplastic syndrome and acute myeloid leukemia.
    Xie J; Briggs JA; Morris SW; Olson MO; Kinney MC; Briggs RC
    Exp Hematol; 1997 Oct; 25(11):1111-7. PubMed ID: 9328447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cloning and expression of the human myeloid cell nuclear differentiation antigen: regulation by interferon alpha.
    Briggs JA; Burrus GR; Stickney BD; Briggs RC
    J Cell Biochem; 1992 May; 49(1):82-92. PubMed ID: 1644857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COX-2 inhibitors sensitize human hepatocellular carcinoma cells to TRAIL-induced apoptosis.
    Yamanaka Y; Shiraki K; Inoue T; Miyashita K; Fuke H; Yamaguchi Y; Yamamoto N; Ito K; Sugimoto K; Nakano T
    Int J Mol Med; 2006 Jul; 18(1):41-7. PubMed ID: 16786154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of flow cytometric assessment of myeloid nuclear differentiation antigen expression as a diagnostic marker for myelodysplastic syndromes in a series of 269 patients.
    Bellos F; Alpermann T; Gouberman E; Haferlach C; Schnittger S; Haferlach T; Kern W
    Cytometry B Clin Cytom; 2012 Sep; 82(5):295-304. PubMed ID: 22508616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role for myeloid nuclear differentiation antigen in the regulation of neutrophil apoptosis during sepsis.
    Fotouhi-Ardakani N; Kebir DE; Pierre-Charles N; Wang L; Ahern SP; Filep JG; Milot E
    Am J Respir Crit Care Med; 2010 Aug; 182(3):341-50. PubMed ID: 20395555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human myeloid cell nuclear differentiation antigen binds specifically to nucleolin.
    Xie J; Briggs JA; Olson MO; Sipos K; Briggs RC
    J Cell Biochem; 1995 Dec; 59(4):529-36. PubMed ID: 8749721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac glycosides initiate Apo2L/TRAIL-induced apoptosis in non-small cell lung cancer cells by up-regulation of death receptors 4 and 5.
    Frese S; Frese-Schaper M; Andres AC; Miescher D; Zumkehr B; Schmid RA
    Cancer Res; 2006 Jun; 66(11):5867-74. PubMed ID: 16740726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative assessment of myeloid nuclear differentiation antigen distinguishes myelodysplastic syndrome from normal bone marrow.
    McClintock-Treep SA; Briggs RC; Shults KE; Flye-Blakemore LA; Mosse CA; Jagasia MH; Shinar AA; Dupont WD; Stelzer GT; Head DR
    Am J Clin Pathol; 2011 Mar; 135(3):380-5. PubMed ID: 21350091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TRAIL (Apo2L) suppresses growth of primary human leukemia and myelodysplasia progenitors.
    Plasilova M; Zivny J; Jelinek J; Neuwirtova R; Cermak J; Necas E; Andera L; Stopka T
    Leukemia; 2002 Jan; 16(1):67-73. PubMed ID: 11840265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toll-like receptor-4 is up-regulated in hematopoietic progenitor cells and contributes to increased apoptosis in myelodysplastic syndromes.
    Maratheftis CI; Andreakos E; Moutsopoulos HM; Voulgarelis M
    Clin Cancer Res; 2007 Feb; 13(4):1154-60. PubMed ID: 17317824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Role of caspase-8 and DR5 in TRAIL-induced apoptosis of neuroblastoma cells].
    Tong HX; Zhang JH; Ma L; Lu CW; Zhang JH
    Zhongguo Dang Dai Er Ke Za Zhi; 2006 Aug; 8(4):327-30. PubMed ID: 16923369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Akt/mammalian target of rapamycin signal transduction pathway is activated in high-risk myelodysplastic syndromes and influences cell survival and proliferation.
    Follo MY; Mongiorgi S; Bosi C; Cappellini A; Finelli C; Chiarini F; Papa V; Libra M; Martinelli G; Cocco L; Martelli AM
    Cancer Res; 2007 May; 67(9):4287-94. PubMed ID: 17483341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tunicamycin sensitizes human melanoma cells to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by up-regulation of TRAIL-R2 via the unfolded protein response.
    Jiang CC; Chen LH; Gillespie S; Kiejda KA; Mhaidat N; Wang YF; Thorne R; Zhang XD; Hersey P
    Cancer Res; 2007 Jun; 67(12):5880-8. PubMed ID: 17575157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KRAS(D13) Promotes apoptosis of human colorectal tumor cells by ReovirusT3D and oxaliplatin but not by tumor necrosis factor-related apoptosis-inducing ligand.
    Smakman N; van den Wollenberg DJ; Elias SG; Sasazuki T; Shirasawa S; Hoeben RC; Borel Rinkes IH; Kranenburg O
    Cancer Res; 2006 May; 66(10):5403-8. PubMed ID: 16707468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GATA-1 transcription factor is up-regulated in bone marrow hematopoietic progenitor CD34(+) and erythroid CD71(+) cells in myelodysplastic syndromes.
    Maratheftis CI; Bolaraki PE; Voulgarelis M
    Am J Hematol; 2007 Oct; 82(10):887-92. PubMed ID: 17570514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Over-expression of tumor necrosis factor-alpha in bone marrow biopsies from patients with myelodysplastic syndromes: relationship to anemia and prognosis.
    Stifter G; Heiss S; Gastl G; Tzankov A; Stauder R
    Eur J Haematol; 2005 Dec; 75(6):485-91. PubMed ID: 16313260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.